Investors are asking: what is the progress of Yooztech's application for an e-cigarette production license?
Yingqu Technology responded that the company has submitted an application for an electronic cigarette production license to the relevant regulatory authorities. The process is currently proceeding according to regulations and specific progress depends on the review by the relevant regulatory authorities. It should be noted that at present, the regulatory authorities mainly require a production license for the whole electronic cigarette product, and the production of components and parts has not been clearly defined. In addition, the company has been continuously expanding its international presence for many years. The capabilities of the overseas smart manufacturing base have been enhanced to meet the diverse needs of customers, including product localization. Obtaining this license will not have a significant impact on the company's current and future business operations.
This article contains excerpts or reprints from third-party sources, whose copyrights belong to the original media and authors. If there is any infringement, please contact us for deletion. If any organization or individual needs to reprint, please contact the author and do not directly reprint.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
